The pharmaceutical sector is experiencing a major shift in glucose care with the arrival of GLP-1 transdermal devices. These groundbreaking methods offer a possibly simple choice to injections for individuals managing diabetes mellitus type 2. By circumventing the necessity for frequent pokes, GL